Plain-English translation of NCT05787197 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This trial is studying a special blood test called circulating tumor DNA (or ctDNA) in people with colorectal cancer that has spread to the liver. Researchers will collect blood samples at different times before, during, and after your liver surgery to see if this blood test can predict whether your cancer might return. The goal is to understand if this test can help doctors better plan your follow-up care and treatment.
Currently, doctors have limited ways to know which patients are at higher risk of their cancer coming back after surgery for liver metastases. This study hopes to show that the special blood test can provide early warning signs of cancer recurrence, which could help doctors catch problems sooner and adjust treatment plans accordingly.
You likely qualify if…
You likely don't qualify if…
You will have blood drawn at specific times related to your surgery—before your operation, possibly during it, and at planned follow-up visits afterward. The exact timing depends on your surgical plan (whether you need one surgery or multiple staged surgeries). These blood samples will be analyzed to look for circulating tumor DNA. Your participation involves working with the surgical and research teams to ensure blood is collected at the right times, and you'll need to be available for follow-up care appointments over the course of the study.
AI-generated summary from trial data · Jun 16, 2026 · Not medical advice
France